These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Glycoxidation and diabetic complications: modern lessons and a warning? Vlassara H; Uribarri J Rev Endocr Metab Disord; 2004 Aug; 5(3):181-8. PubMed ID: 15211089 [No Abstract] [Full Text] [Related]
43. Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children. Gupta A; Uribarri J Horm Res Paediatr; 2016; 85(5):291-300. PubMed ID: 27008270 [TBL] [Abstract][Full Text] [Related]
44. Molecular susceptibility to glycation and its implication in diabetes mellitus and related diseases. Méndez JD; Xie J; Aguilar-Hernández M; Méndez-Valenzuela V Mol Cell Biochem; 2010 Nov; 344(1-2):185-93. PubMed ID: 20680411 [TBL] [Abstract][Full Text] [Related]
45. [Glycoxidative modification of albumin in medical research]. Grzebyk E; Piwowar A Pol Merkur Lekarski; 2013 Apr; 34(202):239-42. PubMed ID: 23745334 [TBL] [Abstract][Full Text] [Related]
46. Diabetes and neurodegeneration in the brain. Toth C Handb Clin Neurol; 2014; 126():489-511. PubMed ID: 25410241 [TBL] [Abstract][Full Text] [Related]
47. [Advances in the Maillard reaction and glycation researches--mainly on the Namiki pathway]. Namiki M Seikagaku; 2003 Jan; 75(1):37-42. PubMed ID: 12645131 [No Abstract] [Full Text] [Related]
48. Can tryptophan oxidation lead to lower tryptophan level in diabetes? A commentary on "Propagation of protein glycation damage involves modification of tryptophan residues via reactive oxygen species: inhibition by pyridoxamine". Jain SK Free Radic Biol Med; 2008 Apr; 44(7):1273-5. PubMed ID: 18261995 [No Abstract] [Full Text] [Related]
50. Impaired Vascular Redox Signaling in the Vascular Complications of Obesity and Diabetes Mellitus. Akoumianakis I; Antoniades C Antioxid Redox Signal; 2019 Jan; 30(3):333-353. PubMed ID: 29084432 [No Abstract] [Full Text] [Related]
51. The Role of Oxidative Stress in the Development of Diabetes Mellitus and Its Complications. Dos Santos JM; Tewari S; Mendes RH J Diabetes Res; 2019; 2019():4189813. PubMed ID: 31192263 [No Abstract] [Full Text] [Related]
52. [Bone diseases caused by impaired glucose and lipid metabolism]. Kanazawa I; Sugimoto T Clin Calcium; 2013 Nov; 23(11):1605-11. PubMed ID: 24162600 [TBL] [Abstract][Full Text] [Related]
55. Diabetes mellitus and Alzheimer's disease: glycation as a biochemical link. Smith MA; Sayre LM; Perry G Diabetologia; 1996 Feb; 39(2):247. PubMed ID: 8635681 [No Abstract] [Full Text] [Related]
56. Natural antibodies as a sensor of electronegative damage-associated molecular patterns (DAMPs). Uchida K Free Radic Biol Med; 2014 Jul; 72():156-61. PubMed ID: 24657731 [TBL] [Abstract][Full Text] [Related]
57. Diabetic periodontitis: a model for activated innate immunity and impaired resolution of inflammation. Nassar H; Kantarci A; van Dyke TE Periodontol 2000; 2007; 43():233-44. PubMed ID: 17214841 [No Abstract] [Full Text] [Related]
58. Advanced glycation in diabetes, aging and age-related diseases: conclusions. Monnier VM; Taniguchi N Glycoconj J; 2016 Aug; 33(4):691-2. PubMed ID: 27421862 [No Abstract] [Full Text] [Related]
59. Metabolic disorders in diabetes mellitus: impact of mitochondrial function and oxidative stress on diabetes and its complications. Araki E; Miyazaki J Antioxid Redox Signal; 2007 Mar; 9(3):289-91. PubMed ID: 17184179 [No Abstract] [Full Text] [Related]
60. Clinical and metabolic study of alcoholic hyperlipidaemia. Chait A; Mancini M; February AW; Lewis B Lancet; 1972 Jul; 2(7767):62-4. PubMed ID: 4113305 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]